Spencer Frederick A, Meyer Theo
Department of Internal Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Curr Cardiol Rep. 2005 Jul;7(4):276-82. doi: 10.1007/s11886-005-0049-8.
Heart failure (HF) complicating acute coronary syndromes (ACS) is a heterogeneous clinical syndrome characterized by varying degrees of pulmonary congestion, and in its severest form, by profound organ hypoperfusion (cardiogenic shock). The occurrence of HF in patients with ACS has long been recognized as a strong predictor of increased morbidity and mortality. As such, there is increased interest in better understanding the epidemiology and management of this common clinical syndrome. This manuscript reviews recent insights from work in this area, including recent important trials evaluating the impact of renin-angiotensin system inhibition, early beta-blockade, and aggressive reperfusion strategies.
并发急性冠脉综合征(ACS)的心力衰竭(HF)是一种异质性临床综合征,其特征为不同程度的肺充血,最严重的形式是严重的器官灌注不足(心源性休克)。ACS患者发生HF长期以来一直被认为是发病率和死亡率增加的有力预测指标。因此,人们越来越有兴趣更好地了解这种常见临床综合征的流行病学和管理方法。本文综述了该领域研究的最新见解,包括评估肾素 - 血管紧张素系统抑制、早期β受体阻滞剂和积极再灌注策略影响的近期重要试验。